IL2RG and severe combined immunodeficiency: In 2005, Urnov, F. D. et al., performed targeted editing of the IL2RG gene in K562 and CD4+ T cells by ZFNs, making it possible to treat X-linked severe combined immune deficiency (SCID) by gene therapy [24].